Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas

por Madanat YF, Smith MR, Almasan A, Hill BT
Publicado 2016

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

por Ujjani C, Mato A, Hill BT, Allan JN, Lansigan E, Jacobs R, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M
Publicado 2020